DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on August 14, 2008; DOI: 10.1124/dmd.108.021659


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.108.021659v1
36/11/2159    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qiu, F.
Right arrow Articles by Yao, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qiu, F.
Right arrow Articles by Yao, X.


Received for publication April 7, 2008.
Revised August 9, 2008.
Accepted for publication August 11, 2008.

Isolation and Identification of Urinary Metabolites of Berberine in Rats and Humans

Feng Qiu 1*, ZhiYong Zhu 1, Ning Kang 1, Shujuan Piao 1, GengYao Qin 1, Xinsheng Yao 1

1 Shenyang Pharmaceutical University

* Address correspondence to: E-mail: fengqiu20070118{at}163.com

Abstract

The urinary metabolites of berberine, an isoquinoline alkaloid isolated from several Chinese herbal medicines, were investigated in rats and humans. Using macroporous adsorption resin chromatography, open ODS column chromatography, and preparative high performance liquid chromatography, seven metabolites (HM1-HM7) were isolated from human urine and five metabolites (RM1-RM5) from rat urine following oral administration were isolated.Their structures were elucidated by enzymatic deconjugation and analyses of MS, 1H-NMR and NOESY spectra. Besides the three known metabolites demethyleneberberine-2-O-sulfate (HM1, RM3), jatrorrhizine-3-O-sulfate (HM5) and thalifendine (RM5), six new metabolites were identified, namely, jatrorrhizine-3-O-{beta}-D-glucuronide (HM2), thalifendine-10-O-{beta}-D-glucuronide (HM3), berberrubine-9-O-{beta}-D-glucuronide (HM4, RM2), 3,10-demethylpalmatine-10-O-sulfate (HM6, RM4), columbamin-2-O-{beta}-D-glucuronide (HM7), and demethyleneberberine-2,3-di-O-{beta}-D-glucuronide (RM1). These findings suggest that berberine undergoes a similar biotransformation in rats and humans. Possible metabolic pathways of berberine in rats and humans are proposed.


Key words: metabolite identification, structure elucidation





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.